An evaluation of diethylhexyl phthalate free top & bottom in-line blood collection set with a new soft housing filter.

Geir Hetland, Elena Danilova, Farshid Ezligini, Connie Stöckel, Masafumi Asakawa

Journal: Transfusion medicine (Oxford, England) 2025;35(1):82-90

PMID: 39243178

Abstract

BACKGROUND AND OBJECTIVES

Di (2-ethylhexyl) phthalate (DEHP) plasticizer must be removed from polyvinylchloride (PVC) medical devices due to toxicity. DEHP/PVC blood bags were shown to provide stable quality under blood component production and to create good storage conditions for red blood cells concentrate (RBC). It is important that substitution of the DEHP maintains the RBC quality during storage, which should be achieved with Di (isononyl) cyclohexane-1,2-dicarboxylate (DINCH), although substitution of the plasticizer has been challenging.

MATERIALS AND METHODS

A DEHP-free Top & Bottom in-line RBC set was validated in a tertiary hospital blood bank facility. Volunteer blood donors were randomly allocated for blood collection into DINCH/PVC or DEHP/PVC set. The groups were additionally divided according to additive solution/filter combination: PAGGS-M + DINCH/PVC filter (only with DINCH/PVC set), and SAG-M + DINCH/PVC filter and SAG-M + DEHP/PVC filter (only with DEHP/PVC set). Processing and storage effects were assessed in all components.

RESULTS

RBC concentrates, platelet concentrates and plasma that was processed and stored in DEHP-free set fulfilled European requirements for quality. The cells stored in PAGGS-M after filtration through DEHP-free PVC filter showed the same low haemolysis compared with conventional set at 49 days of storage. Platelets stored in DINCH/PVC bag provided a sufficient quality of platelets after 7 days of storage. Plasma maintained the coagulation factors during 12 months of storage.

CONCLUSION

A new DINCH/PVC set allows production of blood components of satisfactory quality in DEHP-free environment.

© 2024 The Author(s). Transfusion Medicine published by John Wiley & Sons Ltd on behalf of British Blood Transfusion Society.

Address: Department of Immunology, Oslo University Hospital, Oslo, Norway.; Asahi Kasei Medical Europe GmbH, Asahi Kasei Medical Co., Ltd., Chiyoda, Japan.; Marketing & Sales Department, Sepacell Division, Asahi Kasei Medical Co., Ltd., Chiyoda, Japan.; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Department of Immunology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.